Shots: The EC has approved two regimens of Keytruda (monothx. and in combination with platinum and 5-fluorouracil (5-FU) CT), based on P-III KEYNOTE-048 study evaluating Keytruda vs SoC (cetuximab with […]readmore
Tags : Head and Neck Squamous Cell Carcinoma
Shots: The approval is based on P-III KEYNOTE-048 study results assessing Keytruda as monothx. & in combination with platinum and fluorouracil (FU) vs EXTREME regimen in 882 patients in ratio […]readmore